Mereo BioPharma Group plc Share Price London S.E.
Equities
MPH
GB00BZ4G2K23
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -10.17% | -.--% |
Sales 2024 * | 27.5M 34.45M 2.88B | Sales 2025 * | 12.5M 15.66M 1.31B | Capitalization | 331M 415M 34.67B |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.02M -837M | Net income 2025 * | -28M -35.08M -2.93B | EV / Sales 2024 * | 7.37 x |
Net cash position 2024 * | 128M 161M 13.44B | Net cash position 2025 * | 142M 178M 14.87B | EV / Sales 2025 * | 15.1 x |
P/E ratio 2024 * |
-315
x | P/E ratio 2025 * |
-63.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 01/15/01 |
Founder | 64 | 10/15/10 | |
Charles Sermon
FOU | Founder | 55 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 23/19/23 |
Director/Board Member | - | 10/22/10 | |
Director/Board Member | 59 | 23/19/23 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-2.56% | 21.93B | |
-12.15% | 22.34B | |
-5.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- MREO Stock
- MPH Stock